Alveolar Ridge PreservationNCT06784232
Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition
An observational study of Alveolar Ridge Preservation and Alveolar Bone Loss, run by International Piezosurgery Academy at 1 site in Italy.
Trial summary
The modified periosteal inhibition technique has been proposed as an alternative to limit crestal resorption following tooth extraction in sockets with a residual vestibular thickness of <1 mm. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Alveolar Ridge Preservation, Alveolar Bone Loss
- What is being tested?
- BARP and Modified Periosteal Inhibition Technique
- Type of treatment
- Surgery or procedure
- How many people
- 30 participants
- Where
- 1 siteItaly
- Study dates
- 1 Dec 2024to 31 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study will be conducted in an outpatient hospital setting.
Who may be able to join
- Age between 18 and 80 years;
- Single-rooted tooth with indication for extraction with sockets having a residual thickness of <1 mm in the first 3 mm of the buccal residual crest presenting adjacent teeth;
- American Society of Anesthesiologists 3;
- Periodontal health or stability;
- Signature of informed consent.
Who cannot join
- Presence of periapical cystic lesions at the intervention sites;
- Loss of bone tissue extending to the apical third on radiographic examination;
- Extraction of adjacent teeth within a period ranging from 6 months prior to 6 months after the extraction;
- Lack of one or more walls of the post-extraction socket;
- Presence of general contraindications for oral surgery;
- Presence of inflammatory and autoimmune diseases;
Show all 13Show fewer
- Uncontrolled diabetes (HbA1c 7%);
- History of tumors requiring chemotherapy or radiotherapy in the last 5 years;
- Previous therapy with bisphosphonates or high-dose corticosteroid therapy;
- Smoking (10 cigarettes/day);
- Allergy to bovine collagen;
- Pregnancy or breastfeeding;
- Lack of compliance.
Trial locations and contacts
1 site in 1 country.
About this study
The modified periosteal inhibition technique has been proposed as an alternative to limit crestal resorption following tooth extraction in sockets with a residual vestibular thickness of <1 mm. This technique aims to prevent osteolytic activity on the external surface of a post-extraction socket by applying a 0.5 mm-thick soft cortical plate of porcine origin, secured with fibrin glue. By avoiding the placement of bone graft material inside the socket, the technique seeks to effectively counteract bone remodeling, achieving minimal reduction in the size of the alveolar crest.
The aim is to evaluate the effectiveness of the modified periosteal inhibition technique in preserving the dimensions of the alveolar ridge after tooth extraction, by comparing it with the Biologically-oriented Alveolar Ridge Preservation technique.
Read the detailed description
The primary objective of the study is to clinically compare the effect on the preservation of the alveolar ridge using the modified periosteal inhibition technique and the Biologically-oriented Alveolar Ridge Preservation technique.
The secondary objective is the collection of histological and histomorphometric data that allow to evaluate the quality and quantity of newly formed bone.
Study design: Observational study of a prospective non-profit cohort.
Study population: The study will be conducted in an outpatient hospital setting.
Number of patients to be enrolled to compare modified periosteal inhibition technique and BARP: 30 patients in the University of Trieste including dropouts.
Enrollment procedure: all patients who meet the inclusion and exclusion criteria will be enrolled in the study following the administration of the Information Sheet and the acquisition of informed consent.
The choice of the alveolar ridge preservation protocol will be motivated by the clinicians experience and the patients preference among those currently validated.
BARP: under local anesthesia, the compromised tooth will be extracted atraumatically without raising a flap. After granulation tissue removal, the socket will be filled with a collagen sponge (deep collagen layer) up to 4 to 5 mm from the most coronal extensions of the buccal crest to create a support for the intra-alveolar graft. A bovine derived xenograft will be placed on top of the collagen sponge to fill the coronal part of the socket, avoiding overfilling (graft layer). Socket sealing will be performed with a new layer of collagen sponge that will be placed over the exposed portion of the graft layer and firmly held by sutures.
Modified periosteal inhibition technique: under local anesthesia, an atraumatic tooth extraction will be performed, ensuring the preservation of the buccal bone. After granulation tissue removal, papillae incisions will be made, followed by an intra-sulcular incision along the buccal side of the socket, extending to the mesial and distal mid-tooth regions. A full-thickness flap will be elevated, creating sufficient space within the socket for the insertion of the cortical lamina. The lamina will be trimmed to the required shape, extending to the mesial and distal edges of the extraction socket. A few drops of human fibrin glue (2-3) will be applied to the cortical lamina, which will then be gently pressed against the buccal bone to secure it in place. A collagen sponge will be placed inside the socket to stabilize the clot and held in position with a suture.
For all patients, after 26 weeks of healing, a mucoperiosteal flap will be raised to expose the target site and a titanium implant will be inserted. During this phase, using a core drill to prepare the implant site, it will also be functional to obtain a bone sample that will be subsequently analyzed.
Study Outcomes
The primary endpoint is the width of the alveolar ridge, which will be assessed in two stages:
T0: initial condition of the alveolar ridge, measured before performing surgery; T1: final condition of the alveolar ridge, measured before implant insertion at 26 weeks of healing from surgery.
The primary endpoint will be classified as follows. The secondary endpoints are represented by histomorphometric variables: newly formed mineralized tissue (New bone/Total volume), graft residues (RG/TV), newly formed non-mineralized tissue (Nonmineralised tissue/Total volume), total mineralized tissue that will be assessed at twenty-six weeks of healing (Mineralised tissue/total volume) evaluated as means and standard deviations and with χ2 test.
The primary endpoint will then be assessed in relation to complications and adverse events, such as: soft tissue dehiscence; graft exposure; graft loss and wound infections.
The width of the alveolar ridge will be measured linearly and volumetrically, using digital scans processed by a 3D scanning software (Geomagic Control X, 3D System, Morrisville, USA) at the University of Trieste.
The data collected at follow-up and the outcome data are based on a clinical evaluation, considering the possible presence of complications and adverse events.
The histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and the origin of the biopsy. The biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). The samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then processed for histological and histomorphometric evaluation at the Bone Lab, University of Trieste. After this, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.
Collected data variables and sources The following variables will be collected for each enrolled patient/participant: width of the alveolar ridge; newly formed mineralized tissue; graft residues; non-mineralized newly formed tissue and total mineralized tissue.
Histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and biopsy origin. Biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). Samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then dehydrated in ascending series of alcohol rinses. After 5 days of preinfiltration in a 50% resin/alcohol solution, biopsies will be removed from the core drills and sample infiltration will be completed with methacrylate resin. After 12 days of polymerization, the samples will be cut along their longitudinal axis using a high-precision silicon carbide disc at 50 μm and then finished under running water with a series of polishing discs at approximately 30 ± 10 μm. They will then be mounted on slides and stained with acid fuchsin, toluidine blue and Von Kossa.
Following histological and histomorphometric analyses, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.
Statistical plan The statistical analysis will be performed by means of a computerized statistical package (SigmaStat 3.5, SPSS Inc., Germany). The data will be expressed as mean ± standard deviation and median (interquartile range), respectively, for parametric and non-parametric values.
Sample size calculation The aim of the study is to clinically compare different alveolar ridge preservation techniques. Considering the outcomes of previously published studies, it was calculated that will be necessary to recruit 15 patients for each group to obtain a statistically significant result through a comparison between subpopulations with a statistical power of 95% and a significance of 0.05.
- Conditions
- Alveolar Ridge Preservation, Alveolar Bone Loss
- Being tested
- BARP, Modified Periosteal Inhibition Technique
- Medical subject headings
- Alveolar Bone Loss
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BARPProcedure or surgery
deep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer
Modified Periosteal Inhibition TechniqueProcedure or surgery
Cortical lamina stabilized with human fibrin glue to preserve the buccal wall of the socket. The socket was then filled with collagen.
| Study group | Role | What they receive |
|---|---|---|
| BARP | collagen-bonegraft-collagen Receives: Procedure: BARP | |
| Modified Periosteal Inhibition Technique | cortical lamina, human fibrin glue and collagen Receives: Procedure: Modified Periosteal Inhibition Technique |
What is being measured
The primary outcome is the main question the study is designed to answer.
ridge width reduction
optical scanning comparison measured in millimetres at the mid-buccal and mid-palatal aspect of the socket
Measured: 26 weeks after tooth extraction and preservation tecnhique
ridge height reduction
optical scanning comparison measured in millimetres at the mid-buccal, mid-palatal, mesial and distal aspect of the socket
Measured: 26 weeks after tooth extraction and preservation tecnhique
Secondary outcomes (3)
histologic and histomorphometric analysis of new bone formation
percentage of newly formed bone area to total measured area
Measured: 26 weeks after tooth extraction and preservation tecnhique
histologic and histomorphometric analysis of residual graft particles
percentage of graft particles area to total measured area
Measured: 26 weeks after tooth extraction and preservation tecnhique
histologic and histomorphometric analysis of marrow spaces
percentage of soft tissue area to total measured area
Measured: 26 weeks after tooth extraction and preservation tecnhique
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jan 2025
- Study start1 Dec 2024
- Primary completion31 Dec 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alveolar Ridge PreservationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- International Piezosurgery Academy
- Sponsor type
- University, hospital or other
- Collaborators
- University of Trieste
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06784232
- Sponsor's protocol ID
- PERIOSTEAL INHIBITION
- Status last verified
- Jan 2025
- First submitted
- 14 Jan 2025
- Last updated
- 22 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition
- ClinicalTrials.gov ID
- NCT06784232
- Acronym / sponsor ID
- PERIOSTEAL INHIBITION
- Conditions
- Alveolar Ridge Preservation, Alveolar Bone Loss
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- International Piezosurgery AcademyUniversity, hospital or other
- Collaborators
- University of Trieste
- Study start
- 1 Dec 2024 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 20 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The modified periosteal inhibition technique has been proposed as an alternative to limit crestal resorption following tooth extraction in sockets with a residual vestibular thickness of <1 mm. This technique aims to prevent osteolytic activity on the external surface of a post-extraction socket by applying a 0.5 mm-thick soft cortical plate of porcine origin, secured with fibrin glue. By avoiding the placement of bone graft material inside the socket, the technique seeks to effectively counteract bone remodeling, achieving minimal reduction in the size of the alveolar crest.
The aim is to evaluate the effectiveness of the modified periosteal inhibition technique in preserving the dimensions of the alveolar ridge after tooth extraction, by comparing it with the Biologically-oriented Alveolar Ridge Preservation technique.
Detailed description
The primary objective of the study is to clinically compare the effect on the preservation of the alveolar ridge using the modified periosteal inhibition technique and the Biologically-oriented Alveolar Ridge Preservation technique.
The secondary objective is the collection of histological and histomorphometric data that allow to evaluate the quality and quantity of newly formed bone.
Study design: Observational study of a prospective non-profit cohort.
Study population: The study will be conducted in an outpatient hospital setting.
Number of patients to be enrolled to compare modified periosteal inhibition technique and BARP: 30 patients in the University of Trieste including dropouts.
Enrollment procedure: all patients who meet the inclusion and exclusion criteria will be enrolled in the study following the administration of the Information Sheet and the acquisition of informed consent.
The choice of the alveolar ridge preservation protocol will be motivated by the clinicians experience and the patients preference among those currently validated.
BARP: under local anesthesia, the compromised tooth will be extracted atraumatically without raising a flap. After granulation tissue removal, the socket will be filled with a collagen sponge (deep collagen layer) up to 4 to 5 mm from the most coronal extensions of the buccal crest to create a support for the intra-alveolar graft. A bovine derived xenograft will be placed on top of the collagen sponge to fill the coronal part of the socket, avoiding overfilling (graft layer). Socket sealing will be performed with a new layer of collagen sponge that will be placed over the exposed portion of the graft layer and firmly held by sutures.
Modified periosteal inhibition technique: under local anesthesia, an atraumatic tooth extraction will be performed, ensuring the preservation of the buccal bone. After granulation tissue removal, papillae incisions will be made, followed by an intra-sulcular incision along the buccal side of the socket, extending to the mesial and distal mid-tooth regions. A full-thickness flap will be elevated, creating sufficient space within the socket for the insertion of the cortical lamina. The lamina will be trimmed to the required shape, extending to the mesial and distal edges of the extraction socket. A few drops of human fibrin glue (2-3) will be applied to the cortical lamina, which will then be gently pressed against the buccal bone to secure it in place. A collagen sponge will be placed inside the socket to stabilize the clot and held in position with a suture.
For all patients, after 26 weeks of healing, a mucoperiosteal flap will be raised to expose the target site and a titanium implant will be inserted. During this phase, using a core drill to prepare the implant site, it will also be functional to obtain a bone sample that will be subsequently analyzed.
Study Outcomes
The primary endpoint is the width of the alveolar ridge, which will be assessed in two stages:
T0: initial condition of the alveolar ridge, measured before performing surgery; T1: final condition of the alveolar ridge, measured before implant insertion at 26 weeks of healing from surgery.
The primary endpoint will be classified as follows. The secondary endpoints are represented by histomorphometric variables: newly formed mineralized tissue (New bone/Total volume), graft residues (RG/TV), newly formed non-mineralized tissue (Nonmineralised tissue/Total volume), total mineralized tissue that will be assessed at twenty-six weeks of healing (Mineralised tissue/total volume) evaluated as means and standard deviations and with χ2 test.
The primary endpoint will then be assessed in relation to complications and adverse events, such as: soft tissue dehiscence; graft exposure; graft loss and wound infections.
The width of the alveolar ridge will be measured linearly and volumetrically, using digital scans processed by a 3D scanning software (Geomagic Control X, 3D System, Morrisville, USA) at the University of Trieste.
The data collected at follow-up and the outcome data are based on a clinical evaluation, considering the possible presence of complications and adverse events.
The histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and the origin of the biopsy. The biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). The samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then processed for histological and histomorphometric evaluation at the Bone Lab, University of Trieste. After this, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.
Collected data variables and sources The following variables will be collected for each enrolled patient/participant: width of the alveolar ridge; newly formed mineralized tissue; graft residues; non-mineralized newly formed tissue and total mineralized tissue.
Histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and biopsy origin. Biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). Samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then dehydrated in ascending series of alcohol rinses. After 5 days of preinfiltration in a 50% resin/alcohol solution, biopsies will be removed from the core drills and sample infiltration will be completed with methacrylate resin. After 12 days of polymerization, the samples will be cut along their longitudinal axis using a high-precision silicon carbide disc at 50 μm and then finished under running water with a series of polishing discs at approximately 30 ± 10 μm. They will then be mounted on slides and stained with acid fuchsin, toluidine blue and Von Kossa.
Following histological and histomorphometric analyses, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.
Statistical plan The statistical analysis will be performed by means of a computerized statistical package (SigmaStat 3.5, SPSS Inc., Germany). The data will be expressed as mean ± standard deviation and median (interquartile range), respectively, for parametric and non-parametric values.
Sample size calculation The aim of the study is to clinically compare different alveolar ridge preservation techniques. Considering the outcomes of previously published studies, it was calculated that will be necessary to recruit 15 patients for each group to obtain a statistically significant result through a comparison between subpopulations with a statistical power of 95% and a significance of 0.05.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| BARP | – | Procedure: BARPcollagen-bonegraft-collagen |
| Modified Periosteal Inhibition Technique | – | Procedure: Modified Periosteal Inhibition Techniquecortical lamina, human fibrin glue and collagen |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study will be conducted in an outpatient hospital setting.
Key inclusion criteria (5 listed)
- Age between 18 and 80 years;
- Single-rooted tooth with indication for extraction with sockets having a residual thickness of <1 mm in the first 3 mm of the buccal residual crest presenting adjacent teeth;
- American Society of Anesthesiologists 3;
- Periodontal health or stability;
- Signature of informed consent.
Key exclusion criteria (13 listed)
- Presence of periapical cystic lesions at the intervention sites;
- Loss of bone tissue extending to the apical third on radiographic examination;
- Extraction of adjacent teeth within a period ranging from 6 months prior to 6 months after the extraction;
- Lack of one or more walls of the post-extraction socket;
- Presence of general contraindications for oral surgery;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BARPdeep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer | Procedure or surgery | BARP |
| Modified Periosteal Inhibition TechniqueCortical lamina stabilized with human fibrin glue to preserve the buccal wall of the socket. The socket was then filled with collagen. | Procedure or surgery | Modified Periosteal Inhibition Technique |
Primary outcome
ridge width reduction
Time frame: 26 weeks after tooth extraction and preservation tecnhique
optical scanning comparison measured in millimetres at the mid-buccal and mid-palatal aspect of the socket
ridge height reduction
Time frame: 26 weeks after tooth extraction and preservation tecnhique
optical scanning comparison measured in millimetres at the mid-buccal, mid-palatal, mesial and distal aspect of the socket
3 secondary outcomes
histologic and histomorphometric analysis of new bone formation
Time frame: 26 weeks after tooth extraction and preservation tecnhique
histologic and histomorphometric analysis of residual graft particles
Time frame: 26 weeks after tooth extraction and preservation tecnhique
histologic and histomorphometric analysis of marrow spaces
Time frame: 26 weeks after tooth extraction and preservation tecnhique
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jan 2025.
- Individual participant dataSharing planned: No
Related trials for Alveolar Ridge Preservation
Not yet recruiting
Effect of Ascorbic Acid-Loaded I-PRF With Partially Demineralized Dentin Graft on Alveolar Ridge Preservation
Alveolar Ridge Preservation Post-Extraction Bone Healing Dental Implant Site Development Tooth Loss, Alveolar Bone Regeneration Following Odontectomy
Recruiting
Effect of Collagen Membrane on Ridge Preservation
Dehiscence, Tooth Extraction
Not yet recruitingPhase 1/2
Alveolar Ridge Preservation (ARP) Study Using Alloplastic Biomaterial and a Resorbable Synthetic Membrane. A Digital Workflow (CBCT/Scanner) Evaluates Hard and Soft Tissue Volumetric Changes at 4 Months, Validating Support for the Gingival Phenotype and Buccal Bone Plate.
Alveolar Ridge Augmentation, Bone Substitutes
RecruitingPhase 4
Biotivity A-C Membrane Socket Preservation Study
Alveolar Ridge Preservation
Active, not recruiting
Vallomix Socket Preservation Study
Alveolar Ridge Augmentation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Alveolar Ridge Preservation and Alveolar Bone Loss, run by International Piezosurgery Academy at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 22 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ridge width reduction (time frame: 26 weeks after tooth extraction and preservation tecnhique). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2025.